课题基金 / 基金详情

Extending UK manufacturing capacity through the introduction of continuous processing unit operations

Extending UK manufacturing capacity through the introduction of continuous processing unit operations
通过引入连续加工单元操作扩大英国的制造能力
批准号:
102397
负责人:
金额:
$103.23万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
这是一个合作研发项目,旨在设计、建造和试验一个模块化装置,用于连续生产一系列市场领先的表面活性剂,目前由英国Croda欧洲有限公司生产。基于专利的连续振荡挡板反应器技术,该项目将为现有产品的制造提供一种新工艺,在不影响产品质量的情况下,显著改善运营和资本成本以及工艺可持续性。工艺是专门为与现有批量生产资产集成而设计的,在不需要新的支持基础设施和扩展占地面积的情况下提供更高的产能。该财团认为,30%的运营成本削减目标,加上资本要求的降低,将使投资英国制造业在全球市场上具有竞争力。这个行业主导的四个合作伙伴联盟(Croda, CPI, UoC IfM和NiTech)将建立技术和商业可行性的概念;降低未来对拟议技术进行商业投资的风险。我们将探讨这一创造灵活制造能力的战略对现有商业模式的影响。
英文摘要
A collaborative R&D project to design, build & trial a modular unit for the continuous production of a range of market leading surfactants, currently manufactured in the UK by Croda Europe Ltd. Based on patented Continuous Oscillating Baffle Reactor technology, the project will deliver a new process for the manufacture of existing products, with significant improvements in operational & capital costs & process sustainability without impacting product quality. Processes are specifically designed for integration with existing batch manufacturing assets to provide increased capacity without the need for new supporting infrastructure & extended footprint. The consortium believes that the 30% targeted reduction in operational costs, combined with reduced capital requirements will make investment in UK manufacturing a competitive option in a global market. This industry led, four partner consortium (Croda, CPI, UoC IfM & NiTech) will establish technical & commercial viability of the concept; de-risking future commercial investment in the proposed technology. The impact of this strategy to create flexible manufacturing capacity on existing business models will be explored.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
LncRNA-lincUK介导邻近基因UK组蛋白修 饰调控褐飞虱繁殖力的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    刘凯
  • 依托单位:
CREKA/rhPro-UK靶向载药微泡在腔内超声场下对静脉血栓的除栓作用及机理研究
EEID:US-UK-China: 新发禽流感病毒的演进与生态传播动力学的前瞻性研究
抗真菌药物UK-2A的组合生物合成研究
  • 批准号:
    31970054
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2019
  • 负责人:
    瞿旭东
  • 依托单位: